Tectonic Therapeutic Inc. (TECX) Stock Forecast
TECX analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.70 / 5 from 10 analysts
- Price target
- $71.00 average of analyst targets
- Upside to target
- +243.8% from the latest close
- Next earnings
- November 5, 2026 EPS estimate $-1.38
- 52-week range
- $16.44 – $37.93
TECX analyst ratings
10 analystsNumber of analysts at each rating.
TECX price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
TECX earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$1.21 | −$1.21 | −$1.21 | −$1.02 | −30.4% | 1 |
| Current fiscal year (2026) | −$5.77 | −$5.77 | −$5.77 | −$4.05 | −25.8% | 1 |
| Next fiscal year (2027) | −$4.76 | −$4.76 | −$4.76 | −$5.77 | +17.5% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
TECX revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0 | $0 | $0 | 0.0% | 8 |
| Current fiscal year (2026) | $0 | $0 | $0 | 0.0% | 8 |
| Next fiscal year (2027) | $0 | $0 | $0 | 0.0% | 8 |
TECX EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
TECX EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.00 | $0.00 | $0.00 | $0.00 | −$1.21 | — | 0 up · 0 down |
| Current fiscal year (2026) | $0.00 | $0.00 | $0.00 | $0.00 | −$5.77 | — | 0 up · 0 down |
| Next fiscal year (2027) | $0.00 | $0.00 | $0.00 | $0.00 | −$4.76 | — | 0 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
TECX earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; TECX beat in 5 of 12.
What analysts expect from TECX
10 analysts cover Tectonic Therapeutic; their consensus rating is strong buy (4.70 on a 1–5 scale, where 5 is a strong buy). The average price target is $71.00, 243.8% above the latest close of $20.65. Analysts expect earnings of −$5.77 per share for 2026, −25.8% from a year earlier. For 2027 the average estimate is −$4.76 per share. Tectonic Therapeutic beat the EPS estimate in 5 of the last 12 quarters.
Related: TECX income statement, TECX key metrics, TECX chart. See the TECX stock overview for the latest quote and news.
TECX forecast FAQ
What is Tectonic Therapeutic's price target?
The average analyst price target for Tectonic Therapeutic is $71.00, 243.8% above the latest close of $20.65.
Is Tectonic Therapeutic a buy, hold or sell?
Of 10 analysts covering Tectonic Therapeutic, 8 rate it a strong buy, 1 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Tectonic Therapeutic's EPS forecast?
Analysts forecast −$5.77 per share for 2026 (range −$5.77 to −$5.77); for 2027 the estimate is −$4.76.
When does Tectonic Therapeutic report earnings?
Tectonic Therapeutic is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 after the market closes; the EPS estimate is $-1.38.
Does Tectonic Therapeutic usually beat earnings estimates?
Tectonic Therapeutic reported EPS at or above the analyst estimate in 5 of the last 12 quarters.